China NMPA Product Recall - Respironics V60 Ventilator

The National Medical Products Administration (NMPA) announced a recall by Respironics California, Inc. for its V60 ventilators, reported on July 30, 2013. The recall, managed in China by Philips (China) Investment Co., Ltd., addresses a critical malfunction in the power management board. Routine product monitoring identified an issue with the power management board's PIC software. This defect can, in rare cases, lead to a short circuit, causing the ventilator to shut down. A significant concern is that this malfunction may also prevent the alarm for cessation of respiratory therapy from triggering, posing a serious patient safety risk. The recall affects V60 ventilators and accessory power management boards shipped globally before April 1, 2013, encompassing 16,804 units. Under the NMPA's regulatory guidance, Respironics California, Inc. is implementing two corrective actions. These include upgrading the PIC software for the power management board assembly in all affected V60 ventilators and replacing any unused power management boards shipped before the specified date. These actions are mandated to resolve the identified safety issues and restore product reliability.